Peptide Synthesis - Global Top Players Market Share and Ranking 2025- YH Research

日本语 | 中文

Home > Reports >Chemical & Material > Peptide Synthesis - Global Top Players Market Share and Ranking 2025

Peptide Synthesis - Global Top Players Market Share and Ranking 2025

Publication Date: 2025-09-20
Report Id: 2437777
Industry: Chemical & Material
Report Page: 120
Chart: 116

PDF Download

Publication Date: 2025-09-20
Report Id: 2437777
Industry: Chemical & Material
Report Page: 120
Chart: 116

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Peptide Synthesis Definition
1.2 Global Peptide Synthesis Market Size and Forecast
1.3 China Peptide Synthesis Market Size and Forecast
1.4 Share of China Peptide Synthesis Market with Respect to the Global Market
1.5 Peptide Synthesis Market Size: China VS Global Growth Rate, 2020-2031
1.6 Peptide Synthesis Market Dynamics
1.6.1 Peptide Synthesis Market Drivers
1.6.2 Peptide Synthesis Market Restraints
1.6.3 Peptide Synthesis Industry Trends
1.6.4 Peptide Synthesis Industry Policy

2 Global Leading Players and Market Share
2.1 By Revenue of Peptide Synthesis, Global Market Share by Company, 2020-2025
2.2 Global Peptide Synthesis Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Peptide Synthesis Concentration Ratio
2.4 Global Peptide Synthesis Mergers & Acquisitions, Expansion Plans
2.5 Global Peptide Synthesis Major Companies Product Type
2.6 Head Office and Area Served of Key Players

3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Peptide Synthesis, China Market Share by Company, 2020-2025
3.2 China Peptide Synthesis Peptide Synthesis Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Industry Chain Analysis
4.1 Peptide Synthesis Industry Chain
4.2 Peptide Synthesis Upstream Analysis
4.2.1 Peptide Synthesis Core Raw Materials
4.2.2 Main Manufacturers of Peptide Synthesis Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Peptide Synthesis Production Mode
4.6 Peptide Synthesis Procurement Model
4.7 Peptide Synthesis Industry Sales Model and Sales Channels
4.7.1 Peptide Synthesis Sales Model
4.7.2 Peptide Synthesis Typical Distributors

5 Sights by Type
5.1 Peptide Synthesis Classification by Type
5.1.1 APIs and Intermediates
5.1.2 Peptide preparations
5.2 by Type, Global Peptide Synthesis Consumption Value & CAGR, 2020 VS 2024 VS 2031
5.3 by Type, Global Peptide Synthesis Consumption Value, 2020-2031

6 Sights by Application
6.1 Peptide Synthesis Segment by Application
6.1.1 Commercial
6.1.2 Academic Research
6.2 by Application, Global Peptide Synthesis Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Application, Global Peptide Synthesis Consumption Value, 2020-2031

7 Sales Sights by Region
7.1 By Region, Global Peptide Synthesis Consumption Value, 2020 VS 2024 VS 2031
7.2 By Region, Global Peptide Synthesis Consumption Value, 2020-2031
7.3 North America
7.3.1 North America Peptide Synthesis Market Size & Forecasts, 2020-2031
7.3.2 By Country, North America Peptide Synthesis Market Size Market Share
7.4 Europe
7.4.1 Europe Peptide Synthesis Market Size & Forecasts, 2020-2031
7.4.2 By Country, Europe Peptide Synthesis Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Peptide Synthesis Market Size & Forecasts, 2020-2031
7.5.2 By Country/Region, Asia Pacific Peptide Synthesis Market Size Market Share
7.6 South America
7.6.1 South AmericaPeptide Synthesis Market Size & Forecasts, 2020-2031
7.6.2 By Country, South America Peptide Synthesis Market Size Market Share
7.7 Middle East & Africa

8 Sales Sights by Country Level
8.1 By Country, Global Peptide Synthesis Market Size & CAGR, 2020 VS 2024 VS 2031
8.2 By Country, Global Peptide Synthesis Consumption Value, 2020-2031
8.3 United States
8.3.1 United States Peptide Synthesis Market Size, 2020-2031
8.3.2 by Type, United States Peptide Synthesis Consumption Value Market Share, 2024 VS 2031
8.3.3 by Application, United States Peptide Synthesis Consumption Value Market Share, 2024 VS 2031
8.4 Europe
8.4.1 Europe Peptide Synthesis Market Size, 2020-2031
8.4.2 by Type, Europe Peptide Synthesis Consumption Value Market Share, 2024 VS 2031
8.4.3 by Application, Europe Peptide Synthesis Consumption Value Market Share, 2024 VS 2031
8.5 China
8.5.1 China Peptide Synthesis Market Size, 2020-2031
8.5.2 by Type, China Peptide Synthesis Consumption Value Market Share, 2024 VS 2031
8.5.3 by Application, China Peptide Synthesis Consumption Value Market Share, 2024 VS 2031
8.6 Japan
8.6.1 Japan Peptide Synthesis Market Size, 2020-2031
8.6.2 by Type, Japan Peptide Synthesis Consumption Value Market Share, 2024 VS 2031
8.6.3 by Application, Japan Peptide Synthesis Consumption Value Market Share, 2024 VS 2031
8.7 South Korea
8.7.1 South Korea Peptide Synthesis Market Size, 2020-2031
8.7.2 by Type, South Korea Peptide Synthesis Consumption Value Market Share, 2024 VS 2031
8.7.3 by Application, South Korea Peptide Synthesis Consumption Value Market Share, 2024 VS 2031
8.8 Southeast Asia
8.8.1 Southeast Asia Peptide Synthesis Market Size, 2020-2031
8.8.2 by Type, Southeast Asia Peptide Synthesis Consumption Value Market Share, 2024 VS 2031
8.8.3 by Application, Southeast Asia Peptide Synthesis Consumption Value Market Share, 2024 VS 2031
8.9 India
8.9.1 India Peptide Synthesis Market Size, 2020-2031
8.9.2 by Type, India Peptide Synthesis Consumption Value Market Share, 2024 VS 2031
8.9.3 by Application, India Peptide Synthesis Consumption Value Market Share, 2024 VS 2031
8.10 Middle East & Africa
8.10.1 Middle East & Africa Peptide Synthesis Market Size, 2020-2031
8.10.2 by Type, Middle East & Africa Peptide Synthesis Consumption Value Market Share, 2024 VS 2031
8.10.3 by Application, Middle East & Africa Peptide Synthesis Consumption Value Market Share, 2024 VS 2031

9 Company Profile
9.1 Bachem
9.1.1 Bachem Company Information, Head Office, Market Area, and Industry Position
9.1.2 Bachem Company Profile and Main Business
9.1.3 Bachem Peptide Synthesis Models, Specifications, and Application
9.1.4 Bachem Peptide Synthesis Revenue and Gross Margin, 2020-2025
9.1.5 Bachem Recent Developments
9.2 PolyPeptide
9.2.1 PolyPeptide Company Information, Head Office, Market Area, and Industry Position
9.2.2 PolyPeptide Company Profile and Main Business
9.2.3 PolyPeptide Peptide Synthesis Models, Specifications, and Application
9.2.4 PolyPeptide Peptide Synthesis Revenue and Gross Margin, 2020-2025
9.2.5 PolyPeptide Recent Developments
9.3 CordenPharma
9.3.1 CordenPharma Company Information, Head Office, Market Area, and Industry Position
9.3.2 CordenPharma Company Profile and Main Business
9.3.3 CordenPharma Peptide Synthesis Models, Specifications, and Application
9.3.4 CordenPharma Peptide Synthesis Revenue and Gross Margin, 2020-2025
9.3.5 CordenPharma Recent Developments
9.4 AmbioPharm
9.4.1 AmbioPharm Company Information, Head Office, Market Area, and Industry Position
9.4.2 AmbioPharm Company Profile and Main Business
9.4.3 AmbioPharm Peptide Synthesis Models, Specifications, and Application
9.4.4 AmbioPharm Peptide Synthesis Revenue and Gross Margin, 2020-2025
9.4.5 AmbioPharm Recent Developments
9.5 USV Peptides
9.5.1 USV Peptides Company Information, Head Office, Market Area, and Industry Position
9.5.2 USV Peptides Company Profile and Main Business
9.5.3 USV Peptides Peptide Synthesis Models, Specifications, and Application
9.5.4 USV Peptides Peptide Synthesis Revenue and Gross Margin, 2020-2025
9.5.5 USV Peptides Recent Developments
9.6 Thermofischer
9.6.1 Thermofischer Company Information, Head Office, Market Area, and Industry Position
9.6.2 Thermofischer Company Profile and Main Business
9.6.3 Thermofischer Peptide Synthesis Models, Specifications, and Application
9.6.4 Thermofischer Peptide Synthesis Revenue and Gross Margin, 2020-2025
9.6.5 Thermofischer Recent Developments
9.7 Bio Basic
9.7.1 Bio Basic Company Information, Head Office, Market Area, and Industry Position
9.7.2 Bio Basic Company Profile and Main Business
9.7.3 Bio Basic Peptide Synthesis Models, Specifications, and Application
9.7.4 Bio Basic Peptide Synthesis Revenue and Gross Margin, 2020-2025
9.7.5 Bio Basic Recent Developments
9.8 JPT
9.8.1 JPT Company Information, Head Office, Market Area, and Industry Position
9.8.2 JPT Company Profile and Main Business
9.8.3 JPT Peptide Synthesis Models, Specifications, and Application
9.8.4 JPT Peptide Synthesis Revenue and Gross Margin, 2020-2025
9.8.5 JPT Recent Developments
9.9 Genscript
9.9.1 Genscript Company Information, Head Office, Market Area, and Industry Position
9.9.2 Genscript Company Profile and Main Business
9.9.3 Genscript Peptide Synthesis Models, Specifications, and Application
9.9.4 Genscript Peptide Synthesis Revenue and Gross Margin, 2020-2025
9.9.5 Genscript Recent Developments
9.10 Xinbang Pharma
9.10.1 Xinbang Pharma Company Information, Head Office, Market Area, and Industry Position
9.10.2 Xinbang Pharma Company Profile and Main Business
9.10.3 Xinbang Pharma Peptide Synthesis Models, Specifications, and Application
9.10.4 Xinbang Pharma Peptide Synthesis Revenue and Gross Margin, 2020-2025
9.10.5 Xinbang Pharma Recent Developments
9.11 ScinoPharm
9.11.1 ScinoPharm Company Information, Head Office, Market Area, and Industry Position
9.11.2 ScinoPharm Company Profile and Main Business
9.11.3 ScinoPharm Peptide Synthesis Models, Specifications, and Application
9.11.4 ScinoPharm Peptide Synthesis Revenue and Gross Margin, 2020-2025
9.11.5 ScinoPharm Recent Developments
9.12 SN Biopharm
9.12.1 SN Biopharm Company Information, Head Office, Market Area, and Industry Position
9.12.2 SN Biopharm Company Profile and Main Business
9.12.3 SN Biopharm Peptide Synthesis Models, Specifications, and Application
9.12.4 SN Biopharm Peptide Synthesis Revenue and Gross Margin, 2020-2025
9.12.5 SN Biopharm Recent Developments
9.13 CBL
9.13.1 CBL Company Information, Head Office, Market Area, and Industry Position
9.13.2 CBL Company Profile and Main Business
9.13.3 CBL Peptide Synthesis Models, Specifications, and Application
9.13.4 CBL Peptide Synthesis Revenue and Gross Margin, 2020-2025
9.13.5 CBL Recent Developments
9.14 Piramal Pharma
9.14.1 Piramal Pharma Company Information, Head Office, Market Area, and Industry Position
9.14.2 Piramal Pharma Company Profile and Main Business
9.14.3 Piramal Pharma Peptide Synthesis Models, Specifications, and Application
9.14.4 Piramal Pharma Peptide Synthesis Revenue and Gross Margin, 2020-2025
9.14.5 Piramal Pharma Recent Developments
9.15 CPC Scientific
9.15.1 CPC Scientific Company Information, Head Office, Market Area, and Industry Position
9.15.2 CPC Scientific Company Profile and Main Business
9.15.3 CPC Scientific Peptide Synthesis Models, Specifications, and Application
9.15.4 CPC Scientific Peptide Synthesis Revenue and Gross Margin, 2020-2025
9.15.5 CPC Scientific Recent Developments
9.16 Shenzhen Hanyu
9.16.1 Shenzhen Hanyu Company Information, Head Office, Market Area, and Industry Position
9.16.2 Shenzhen Hanyu Company Profile and Main Business
9.16.3 Shenzhen Hanyu Peptide Synthesis Models, Specifications, and Application
9.16.4 Shenzhen Hanyu Peptide Synthesis Revenue and Gross Margin, 2020-2025
9.16.5 Shenzhen Hanyu Recent Developments

10 Conclusion

11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer

According to YH Research, the global market for Peptide Synthesis should grow from US$ 743 million in 2024 to US$ 1137 million by 2031, with a CAGR of 6.3% for the period of 2025-2031.

Peptide synthesis refers to the process of linking multiple amino acids into a peptide chain in a specified sequence by chemical or biochemical methods. These peptides may serve as therapeutics, diagnostic reagents, biomarkers, or research tools. Peptides are generally shorter than proteins — most often composed of no more than 40-60 amino acid residues — though their structures can be complex, including non-natural or modified amino acids, cyclizations, conjugations with chemical moieties or labels. The main techniques for peptide synthesis include solid-phase peptide synthesis (SPPS), liquid-phase peptide synthesis (LPPS), hybrid/convergent methods, enzymatic or recombinant expression methods. The synthetic workflow typically involves protecting and deprotecting amino acids, peptide bond formation (coupling), support/resin anchoring or carrier systems, purification (such as chromatographic steps, precipitations, etc.), and rigorous quality control (structure confirmation, stereochemical purity, impurity/residual solvent analysis). With the rapid expansion of peptide-based drugs, diagnostics, and cosmetic applications, combined with growing demand for high specificity, low toxicity, and strong biocompatibility, peptide synthesis has become a cornerstone in biopharma and life science R&D.

Peptide Synthesis

According to YH Research, the global market for Peptide Synthesis should grow from US$ 743 million in 2024 to US$ 1137 million by 2031, with a CAGR of 6.3% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

The peptide synthesis market currently stands at a multi-accelerated inflection point. On one side, peptide-based therapeutics are being increasingly recognized in fields such as chronic diseases, metabolic disorders, oncology, and neurodegeneration: their high specificity, low systemic toxicity, and novel targeting mechanisms make them promising where traditional small molecules or large proteins struggle. On another side, governments and regulatory agencies in many countries (including the U.S., EU, Japan, China, etc.) are introducing policies that support innovation, streamline approval pathways for novel peptides or peptide/oligonucleotide (TIDES) drugs, and shorten clinical trial and regulatory review timelines, thereby enlarging market opportunity for peptide synthesis providers. On the technical front, continued progress in solid-phase synthesis (SPPS), liquid-phase methods (LPPS), hybrid / convergent synthesis, and enhanced capabilities for complex structures (including non-natural amino acids, cyclization, peptide-drug conjugates) are pushing the market toward larger scale, higher quality, and greater structural diversity. In addition, downstream CDMO/CRO outsourcing demand is rising sharply: drug developers are increasingly preferring to externalize process development, scale-up, and clinical/registration production to specialized synthesis/manufacturing entities to reduce capital burden and risk. Emerging economies (e.g. China, India, South Korea) are also providing strong growth drivers due to their rising healthcare needs, biotech investment, lower manufacturing cost bases, and favorable policy incentives.

However, the peptide synthesis market is not without substantial challenges and risks. First, synthesizing long or complex peptides (with modifications, non-natural residues, cyclization, hydrophobic sequences etc.) amplifies problems of low coupling efficiency, incomplete reactions, racemization, side-product formation — these reduce yield and make purification expensive and difficult. Second, the supply chain stability and cost volatility for upstream raw materials (high-purity protected amino acids, specialized coupling reagents, protective groups, rare or synthetic modified amino acids) is high; environmental / safety laws regulating chemical reagents and solvents impose increasing constraints. Third, downstream purification and quality control steps (chromatography, removal of residual reagents/protection groups/solvents, structure confirmation, stereochemical purity) require heavy equipment investment, long cycles, and high operating costs, particularly at clinical/commercial scale. Regulatory risk is also real: differing national definitions of peptides vs biologics (or other categories), regulatory standards, and environmental / chemical safety policies may shift, increasing compliance cost or causing delays. Finally, competitive pressures and pricing squeeze are intensifying, especially among CDMOs / synthesis service providers, and in emerging markets focusing on low cost; maintaining high quality, speed, and regulatory compliance becomes a differentiator but also a cost center.

Downstream demand is evolving in several concurrent directions. Therapeutic peptides continue to be the largest pull: more peptide drugs are gaining regulatory approval, and the R&D pipeline is expanding, especially in metabolic disease (e.g. obesity, diabetes), oncology, endocrine regulation, and infectious diseases. In several disease areas, peptide-drug conjugates and peptide vaccines are emerging as key focus areas. Beyond therapeutics, diagnostic and imaging labelled peptides are growing demand, e.g. biomarkers, in vitro diagnostics (IVD) and radiolabelled or fluorescent labelled small peptides, especially in precision medicine. The cosmetics / beauty sector is also actively introducing peptides with anti-aging, repair, collagen-boosting, antioxidative functionalities, with rising consumer and brand expectations for natural or bio-active, safety validated ingredients. Research and basic science needs remain stable, being driven by automation and high-throughput synthesis tools, giving academic institutions and biotech startups need for more flexible, fast, custom peptide synthesis services. Overall, downstream demand is trending toward more complex structures / high modifications / higher purity / more individualized use, and demands for faster turnaround and higher service quality.

This report studies and analyses global Peptide Synthesis status and future trends, to help determine the Peptide Synthesis market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Peptide Synthesis, and provides market size (US$ million) and Year-over-Year growth, considering 2024 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Peptide Synthesis market size, history data 2020-2025, and forecast data 2026 -2031, (US$ million)
(2) Global Peptide Synthesis by company, revenue, market share and industry ranking 2020-2025, (US$ million)
(3) China Peptide Synthesis by company, revenue, market share and industry ranking 2020-2025, (US$ million)
(4) Global Peptide Synthesis key consuming regions, consumption value and demand structure
(5) Peptide Synthesis industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Bachem
PolyPeptide
CordenPharma
AmbioPharm
USV Peptides
Thermofischer
Bio Basic
JPT
Genscript
Xinbang Pharma
ScinoPharm
SN Biopharm
CBL
Piramal Pharma
CPC Scientific
Shenzhen Hanyu

Market segment by Type, covers
APIs and Intermediates
Peptide preparations

Market segment by Application, can be divided into
Commercial
Academic Research

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Peptide Synthesis product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Peptide Synthesis market share and ranking of major manufacturers, revenue, 2020-2025
Chapter 3: China Peptide Synthesis market share and ranking of major manufacturers, revenue, 2020-2025
Chapter 4: Peptide Synthesis industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2020-2031
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2020-2031
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2020-2031
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2020-2031
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions